BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
18 results:

  • 1. Divergent Lineage Markers in Anaplastic thyroid Carcinoma.
    Mneimneh WS; Asa SL
    Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical characteristics and prognostic analysis of smarca4-deficient non-small cell lung cancer.
    Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
    Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Overexpression of Both Human Sodium Iodide Symporter (NIS) and brg1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression.
    Na J; Lee CH; Chung JK; Youn H
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769088
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Analysis of Clinicopathologic Features of 9 Cases of 
smarca4-deficient Non-small Cell Lung cancer].
    Zhao R; Zou Y; Chen H; Chen Y; Liu Y; He M
    Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):575-582. PubMed ID: 36002194
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cytomorphologic and immunophenotypical analysis of smarca4 (brg1)-deficient non-small cell lung carcinoma.
    Ogunbona OB; Lin X; Hornick JL; Lubin DJ; Wang Q; Reid MD; Schneider F; Li D; Shin DM; Shi Q
    J Am Soc Cytopathol; 2022; 11(4):183-193. PubMed ID: 35491322
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expanding the Immunophenotype Spectrum of smarca4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
    Mao R; Liu M; Shu X; Li W; Yan W; Li X
    Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
    [No Abstract]    [Full Text] [Related]  

  • 7. smarca4 (brg1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma.
    Gandhi JS; Alnoor F; Sadiq Q; Solares J; Gradowski JF
    Pathol Res Pract; 2021 Mar; 219():153341. PubMed ID: 33581550
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. smarca4/brg1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
    Nambirajan A; Singh V; Bhardwaj N; Mittal S; Kumar S; Jain D
    Arch Pathol Lab Med; 2021 Jan; 145(1):90-98. PubMed ID: 33367658
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
    Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
    Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting brg1.
    Chang Y; Cui M; Fu X; Zhang L; Li X; Li L; Wu J; Sun Z; Zhang X; Li Z; Nan F; Yan J; Zhang M
    Cancer Biol Ther; 2019; 20(1):31-41. PubMed ID: 30299211
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.
    Gillis NE; Taber TH; Bolf EL; Beaudet CM; Tomczak JA; White JH; Stein JL; Stein GS; Lian JB; Frietze S; Carr FE
    Endocrinology; 2018 Jun; 159(6):2484-2494. PubMed ID: 29750276
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-β-Catenin-brg1 Transcriptional Network-Driven CD47 Expression.
    Gowda P; Patrick S; Singh A; Sheikh T; Sen E
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463646
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
    Oishi N; Kondo T; Ebina A; Sato Y; Akaishi J; Hino R; Yamamoto N; Mochizuki K; Nakazawa T; Yokomichi H; Ito K; Ishikawa Y; Katoh R
    Mod Pathol; 2017 Nov; 30(11):1527-1537. PubMed ID: 28731042
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. FDG-PET characteristics of Hürthle cell and follicular adenomas.
    Pathak KA; Klonisch T; Nason RW; Leslie WD
    Ann Nucl Med; 2016 Aug; 30(7):506-9. PubMed ID: 27221817
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.
    Costa V; Esposito R; Ziviello C; Sepe R; Bim LV; Cacciola NA; Decaussin-Petrucci M; Pallante P; Fusco A; Ciccodicola A
    Oncotarget; 2015 May; 6(13):11242-51. PubMed ID: 25803323
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lung cancer with loss of brg1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.
    Matsubara D; Kishaba Y; Ishikawa S; Sakatani T; Oguni S; Tamura T; Hoshino H; Sugiyama Y; Endo S; Murakami Y; Aburatani H; Fukayama M; Niki T
    Cancer Sci; 2013 Feb; 104(2):266-73. PubMed ID: 23163725
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.
    Doyon Y; Selleck W; Lane WS; Tan S; Côté J
    Mol Cell Biol; 2004 Mar; 24(5):1884-96. PubMed ID: 14966270
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly population.
    Ravaglia G; Forti P; Maioli F; Sacchetti L; Nativio V; Scali CR; Mariani E; Zanardi V; Stefanini A; Macini PL
    Exp Gerontol; 2002 May; 37(5):701-12. PubMed ID: 11909687
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.